[1] Park S, Kim D S, Kang S. Vitamin D deficiency impairs glucose-stimulated insulin secretion and increases insulin resistance by reducing PPAR-gamma expression in nonobese Type 2 diabetic rats. J Nutr Biochem. 27, 257-265; 10.1016/j.jnutbio.2015.09.013 (2016).
[2] Zhou Q G, Hou F F, Guo Z J, et al. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 24: 459-464; 10.1002/dmrr.873 (2008).
[3] Gysemans C A, Cardozo A K, Callewaert H, et al. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology. 146:1956-1964; 10.1210/en.2004-1322 (2005).
[4] Ekmekcioglu C, Haluza D, Kundi M. 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies. Int J Environ Res Public Health. 14: 127; 10.3390/ijerph14020127 (2017).
[5] Ye Z, Sharp S J, Burgess S, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 3: 35-42; 10.1016/S2213-8587(14)70184-6 (2015).
[6] Song Y, Wang L, Pittas A G, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 36: 1422-1428; 10.2337/dc12-0962 (2013).
[7] Wang L, Gao P, Zhang M, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013. JAMA. 317: 2515-2523; 10.1001/jama.2017.7596 (2017).
[8] Yu S, Fang H, Han J, et al. The high prevalence of hypovitaminosis D in China: a multicenter vitamin D status survey. Medicine (Baltimore). 94: e585; 10.1097/MD.0000000000000585 (2015).
[9] Kodama K, Tojjar D, Yamada S, et al. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 36: 1789-1796; 10.2337/dc12-1235 (2013).
[10] Pittas A G, Nelson J, Mitri J, et al. Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care. 35: 565-573;10.2337/dc11-1795 (2012).
[11] Pittas A G, Sun Q, Manson J E, et al. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care. 33: 2021-2023;10.2337/dc10-0790 (2010).
[12] Husemoen L L, Skaaby T, Thuesen B H, et al. Serum 25(OH)D and incident type 2 diabetes: a cohort study. Eur J Clin Nutr. 66: 1309-1314;10.1038/ejcn.2012.134 (2012).
[13] Lu L, Bennett D A, Millwood I Y, et al. Association of vitamin D with risk of type 2 diabetes: A Mendelian randomisation study in European and Chinese adults. PLoS Med. 15: e1002566; 10.1371/journal.pmed.1002566 (2018).
[14] Leung R Y, Cheung B M, Tan K C, et al. 25-Hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese. Public Health Nutr. 23:1201-1207; 10.1017/S1368980019000582 (2020).
[15] Pittas A G, Dawson-Hughes B, Sheehan P, et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med. 381: 520-530;10.1056/NEJMoa1900906 (2019).
[16] Mathieu C. Vitamin D and diabetes: Where do we stand?. Diabetes Res Clin Pract. 108: 201-209; 10.1016/j.diabres.2015.01.036 (2015).
[17] Deleskog A, Hilding A, Brismar K, et al. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia. 55: 1668-1678; 10.1007/s00125-012-2529-x (2012).
[18] Afzal S, Bojesen S E, Nordestgaard B G. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem. 59: 381-391;10.1373/clinchem.2012.193003 (2013).
[19] Kabadi S M, Lee B K, Liu L. Joint effects of obesity and vitamin D insufficiency on insulin resistance and type 2 diabetes: results from the NHANES 2001-2006. Diabetes Care. 35: 2048-2054;10.2337/dc12-0235 (2012).
[20] Argyridou S, Bernieh D, Henson J, et al. Associations between physical activity and trimethylamine N-oxide in those at risk of type 2 diabetes. BMJ Open Diabetes Res Care. 8; e001359;10.1136/bmjdrc-2020-001359 (2020).
[21] Fu B C, Hullar M, Randolph T W, et al. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study. Am J Clin Nutr. 111: 1226-1234;10.1136/bmjdrc-2020-001359 (2020).
[22] Fennema D, Phillips I R, Shephard E A. Trimethylamine and Trimethylamine N-Oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-Mediated Host-Microbiome Metabolic Axis Implicated in Health and Disease. Drug Metab Dispos. 44: 1839-1850;10.1124/dmd.116.070615 (2016).
[23] Wang X, Li X, Dong Y. Vitamin D Decreases Plasma Trimethylamine-N-oxide Level in Mice by Regulating Gut Microbiota. Biomed Res Int. 2020: 9896743;10.1155/2020/9896743 (2020).
[24] Barrea L, Muscogiuri G, Annunziata G, et al. A New Light on Vitamin D in Obesity: A Novel Association with Trimethylamine-N-Oxide (TMAO). Nutrients. 11:1310; 10.3390/nu11061310 (2019).
[25] Nargesi A A, Heidari B, Esteghamati S, et al. Contribution of vitamin D deficiency to the risk of coronary heart disease in subjects with essential hypertension. Atherosclerosis. 244: 165-171;10.1016/j.atherosclerosis.2015.11.020 (2016).
[26] Gerling M E, James M T, Wilton S B, et al. Serum Total 25-OH Vitamin D Adds Little Prognostic Value in Patients Undergoing Coronary Catheterization. J Am Heart Assoc. 5: e004289;10.1161/JAHA.116.004289 (2016).
[27] American Diabetes Association. Classification and Diagnosis of Diabetes. Diabetes Care. 38: S8-S16; 10.2337/dc15-S005 (2015).
[28] Guthold R, Louazani S A, Riley L M, et al. Physical activity in 22 African countries: results from the World Health Organization STEPwise approach to chronic disease risk factor surveillance. Am J Prev Med. 41: 52-60; 10.1016/j.amepre.2011.03.008 (2011).
[29] Zhou B F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci. 15: 83-96; https://pubmed.ncbi.nlm.nih.gov/12046553/ (2002).
[30] Holick M F, Binkley N C, Bischoff-Ferrari H A, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 96: 1911-1930; 10.1210/jc.2011-0385 (2011).
[31] 2016 Chinese guideline for the management of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi. 44: 833-853; 10.3760/cma.j.issn.0253-3758.2016.10.005 (2016).
[32] Ahlbom A, Alfredsson L. Interaction: A word with two meanings creates confusion. Eur J Epidemiol. 20: 563-564; 10.1007/s10654-005-4410-4 (2005).
[33] Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol. 20: 575-579;10.1007/s10654-005-7835-x (2005).
[34] Pencina M J, D'Agostino R S, D'Agostino R J, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008, 27: 157-172; 10.1002/sim.2929 (2008).
[35] Pencina M J, D'Agostino R S, Steyerberg E W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 30: 11-21; 10.1002/sim.4085 (2011).